Harriett Taggart - Hanover Insurance Independent Director
| THG Stock | USD 127.21 0.60 0.47% |
Director
Dr. Harriett Tee Taggart Ph.D., is an Independent Director of the Company. Ms. Taggart currently manages a professional practice, Taggart Associates. She also serves as an endowment investment committee member, evaluating global portfolio managers and asset allocation strategies, for several major nonprofit organizations. From 1983 through 2006, Ms. Taggart was a Partner, Senior Vice President and sector portfolio manager at Wellington Management LLC, a global investment company. Ms. Taggart is a director of Albemarle Corporationrationration, a publicly traded specialty chemical manufacturer. Ms. Taggart served as a trustee of the Eaton Vance Mutual Fund Complex from September 2011 to December 2018 since 2009.
| Age | 73 |
| Tenure | 15 years |
| Address | 440 Lincoln Street, Worcester, MA, United States, 01653 |
| Phone | 508 855 1000 |
| Web | https://www.hanover.com |
Hanover Insurance Management Efficiency
The current Return On Tangible Assets is estimated to decrease to 0. The current Return On Capital Employed is estimated to decrease to 0.0003. At this time, Hanover Insurance's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Hanover Insurance's current Intangible Assets is estimated to increase to about 243.4 M, while Other Assets are projected to decrease to roughly 8.8 B. Hanover Insurance's management efficiency ratios could be used to measure how well Hanover Insurance manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Jose Montemayor | CNA Financial | 70 | |
| Bruce Lederman | Global Indemnity PLC | 77 | |
| Marvin Zonis | CNA Financial | 82 | |
| Cynthia Nicholson | Selective Insurance Group | 53 | |
| Michael Eskew | The Allstate | 71 | |
| James Cash | Chubb | 71 | |
| Barbara Allen | RLI Corp | 63 | |
| Joseph Brown | Global Indemnity PLC | 75 | |
| Richard Wampler | Donegal Group B | 76 | |
| Kevin Kraft | Donegal Group B | 65 | |
| Jack Hess | Donegal Group B | 70 | |
| Bradley Sheares | Progressive Corp | 59 | |
| Peter Menikoff | Chubb | 74 | |
| Kaj Ahlmann | RLI Corp | 70 | |
| Lowndes Smith | White Mountains Insurance | 78 | |
| Zoe Budinger | Chubb | 61 | |
| James Scanlan | RLI Corp | 62 | |
| John Baily | RLI Corp | 77 | |
| Perry Hines | Horace Mann Educators | 57 | |
| Sewell Moore | Donegal Group B | 64 | |
| Paul Liska | CNA Financial | 58 | |
Management Performance
| Return On Equity | 0.014 | ||||
| Return On Asset | 0.0033 |
Hanover Insurance Leadership Team
Elected by the shareholders, the Hanover Insurance's board of directors comprises two types of representatives: Hanover Insurance inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hanover. The board's role is to monitor Hanover Insurance's management team and ensure that shareholders' interests are well served. Hanover Insurance's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hanover Insurance's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Fowle, CEO - Chaucer Syndicates, Ltd. | ||
| Joseph Zubretsky, President CEO, Director | ||
| P Condron, Independent Chairman of the Board | ||
| Harriett Taggart, Independent Director | ||
| Cynthia Egan, Independent Vice Chairman of the Board | ||
| Jeffrey Farber, Chief Financial Officer, Executive Vice President, Senior Finance Officer | ||
| Kendall Huber, Executive VP, General Counsel and Assistant Secretary | ||
| Andrew Robinson, Executive VP of Corporate Devel. and President of Specialty Insurance | ||
| Jennifer Luisa, VP Officer | ||
| Mark Keim, Executive Vice President Corporate Development and Strategy | ||
| Theodore Bunting, Independent Director | ||
| Warren Barnes, Senior Vice President and Corporate Controller and Principal Accounting Officer | ||
| Christine BilottiPeterson, Chief Human Resource Officer, Senior Vice President | ||
| Lindsay Greenfield, Senior Officer | ||
| Mark Berthiaume, Executive Vice President, Chief Technology Innovation Officer | ||
| Denise Lowsley, Chief Human Resource Officer, Executive Vice President | ||
| Mina Rona, President Sciences | ||
| Kathleen Lane, Independent Director | ||
| Oksana Lukasheva, IR Contact Officer | ||
| Johan Slabbert, CEO of Chaucer | ||
| Jane Carlin, Independent Director | ||
| J Huber, Executive Vice President General Counsel, Assistant Secretary | ||
| Richard Booth, Director | ||
| Kevin Bradicich, Independent Director | ||
| Bryan Salvatore, Executive Vice President and Presidentident - Specialty | ||
| Karen Francis, Director | ||
| Sarah Medina, President - Professional Liability | ||
| Scott Grieco, Chief Product and Underwriting officer | ||
| Michael Angelini, Independent Chairman of the Board | ||
| Martin Hughes, Independent Director | ||
| John Roche, Senior Vice President and Presidentident - Business Insurance | ||
| Ann Tripp, Executive Vice President, Chief Investment Officer, Treasurer and President, Opus Investment Management, Inc. | ||
| Matthew Mitchell, President - Hanover's middle market business | ||
| James Kelley, President - Hanover Specialty Industrial Property | ||
| Richard Lavey, Senior Vice President Chief Marketing and Distribution Officer | ||
| Kathleen DeCastro, Chief Human Resource Officer, Executive Vice President | ||
| Gayle Falvey, VP COO | ||
| Mark Welzenbach, Executive Vice President, Chief Claims Officer | ||
| Carrick Bligh, Vice President - Commercial Surety | ||
| Frederick Eppinger, CEO and President and Director | ||
| Wendell Knox, Independent Director | ||
| Willard Lee, Senior Vice President, Chief Technology Innovation Officer, Chief Information Officer | ||
| Daniel Henry, Independent Director | ||
| Kevin Condron, Independent Director | ||
| J Condrin, Independent Director | ||
| Dennis Kerrigan, Executive Vice President General Counsel, Assistant Secretary | ||
| Robert Stuchbery, President of International Operations and CEO of Chaucer | ||
| Eugene Bullis, Interim CFO | ||
| Joseph Ramrath, Independent Director | ||
| Neal Finnegan, Independent Director | ||
| Frank Baron, President of Alternative Markets | ||
| Michael Price, Independent Director |
Hanover Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hanover Insurance a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.014 | ||||
| Return On Asset | 0.0033 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 5.02 B | ||||
| Shares Outstanding | 35.93 M | ||||
| Shares Owned By Insiders | 0.87 % | ||||
| Shares Owned By Institutions | 87.61 % | ||||
| Number Of Shares Shorted | 360.09 K | ||||
| Price To Earning | 18.15 X |
Currently Active Assets on Macroaxis
When determining whether Hanover Insurance is a strong investment it is important to analyze Hanover Insurance's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Hanover Insurance's future performance. For an informed investment choice regarding Hanover Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in The Hanover Insurance. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Hanover Insurance information on this page should be used as a complementary analysis to other Hanover Insurance's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Hanover Stock analysis
When running Hanover Insurance's price analysis, check to measure Hanover Insurance's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hanover Insurance is operating at the current time. Most of Hanover Insurance's value examination focuses on studying past and present price action to predict the probability of Hanover Insurance's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hanover Insurance's price. Additionally, you may evaluate how the addition of Hanover Insurance to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Hanover Insurance's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hanover Insurance. If investors know Hanover will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hanover Insurance listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 16.105 | Dividend Share 3.28 | Earnings Share 0.93 | Revenue Per Share 167.885 | Quarterly Revenue Growth 0.034 |
The market value of Hanover Insurance is measured differently than its book value, which is the value of Hanover that is recorded on the company's balance sheet. Investors also form their own opinion of Hanover Insurance's value that differs from its market value or its book value, called intrinsic value, which is Hanover Insurance's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hanover Insurance's market value can be influenced by many factors that don't directly affect Hanover Insurance's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hanover Insurance's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hanover Insurance is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hanover Insurance's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.